The presence of tumor-infiltrating mast cells are associated with downmodulation of HLA-class I on tumor cells, lack of CD8+ T cells in these areas, and in effective tumor killing and eventual immune escape after anti-PD-1 therapy39. This evidence concerns the gene CD8A and neoplasm.